GLP-1 drugs, including Wegovy, Zepbound, and Foundayo, help patients lose weight by mimicking a hormone that makes the body ...

Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 ...

GSK will acquire a trispecific T cell engager for multiple myeloma from Chimagen Biosciences in a deal worth up to $750 ...

Nigeria’s corporate exodus story is now familiar, with ride-hailing app Uber’s September 2nd exit, after twelve years in the market, the latest. Recently, hypermarket giant Shoprite has wound down its ...

GSK trades at GBX1,860.50 today, up 0.4%. Key technicals highlight sideways movement and volatility in the short term.

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (NYSE: GSK) from Hold to Buy with a price target of $60.00 (from $54.00). For an analyst ratings summary and ratings ...

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Hold to Buy with a price target of GBP22.00 (from GBP20.00).The analyst comments: Following the spin-off ...

Shareholders approved appointment of Karine Natland as non-executive director with 99.71% vote share. Bhushan Akshikar re-appointed as managing director with 99.71% shareholder approval. Promoter ...

Vaccine production in Germany's Dresden is set to end after 115 years, with pharmaceutical group GlaxoSmithKline (GSK) ...

Vaccine production in Dresden is set to end after 115 years, with pharmaceutical group GlaxoSmithKline (GSK) announcing plans ...

The pharmaceutical company GlaxoSmithKline plans to close its long-standing facility in Dresden by the summer of 2028. Global demand for vaccines is declining. What happens next. After 115 years, ...

According to the union, the pharmaceutical company GlaxoSmithKline plans to close its facility in Dresden by 2028. What does this mean for the more than 600 employees? According to the union, the ...